USPTO serial 79350973
ARICEUM
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 5, 2024
- Examiner
- EISNACH, MICHAEL PATRICK
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with ARICEUM?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Molly Buck Richard
Molly Buck Richard RICHARD LAW GROUP5910 N. Central ExpresswaySuite 325DALLAS, TX 75206Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceuticals for use in the treatment of cancer; pharmaceutical drugs for use in the treatment of cancer; pharmaceutical preparations for use in the treatment of cancer; injectable pharmaceuticals for use in the treatment of cancer; chemico-pharmaceutical preparations for use in the treatment of cancer; pharmaceutical preparations and substances for use in the treatment of cancer; pharmaceutical preparations for human use for use in the treatment of cancer; synthetic peptides for pharmaceutical purposes for use in the diagnosis and treatment of cancer; pharmaceutical preparations for medical purposes for use in the treatment of cancer; pharmaceutical preparations for the prevention of tumours; pharmaceutical preparations for the treatment of tumours; pharmaceutical preparations for the treatment of cancer; pharmaceutical products for the treatment of cancer; pharmaceutical preparations and substances for use in oncology; radioactive substances for medical purposes; radioactive materials for medical purposes; radioactive elements for medical use | ACTIVE | — |
| 042 | Pharmaceutical products development; pharmaceutical product evaluation; testing of pharmaceuticals; research of pharmaceuticals; pharmaceutical research and development; research relating to pharmaceuticals; conducting clinical trials for pharmaceutical products of others; development of pharmaceutical preparations and medicines; research on the subject of pharmaceuticals; research and development for the pharmaceutical industry; research and development in the pharmaceutical and biotechnology fields; conducting clinical trials for others; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of pharmaceutical preparations for treating malignant tumours | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Ariceum Therapeutics GmbH
- Other trademarks owned by Ariceum Therapeutics GmbH
- Other trademarks owned by Ariceum Therapeutics GmbH
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named ARICEUM
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 12, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 12, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 12, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 16, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 6, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 6, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 6, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Mar 5, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Mar 5, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 19, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Dec 19, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 19, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 29, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 29, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Nov 29, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 13, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 10, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 9, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 9, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 7, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 20, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 20, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 15, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 14, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 8, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 4, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 30, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 29, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |